NeuroFlow
Financials
Estimates*
USD | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Revenues | 1.3m | 3.1m | 7.4m | 9.1m | 25.5m | 28.2m |
% growth | - | 142 % | 138 % | 24 % | 180 % | 11 % |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$1.3m | Seed | ||
* | $1.2m | Early VC | |
N/A | N/A | Series A | |
$7.5m | Series A | ||
$750k | Grant | ||
$20.0m | Series B | ||
* | $25.0m | Growth Equity VC | |
* | $500k | Grant | |
* | N/A | Growth Equity VC | |
Total Funding | €51.1m |
Related Content
Recent News about NeuroFlow
EditNeuroFlow operates in the healthcare technology sector, providing a platform designed to remotely track and manage mental health. The company serves a diverse range of clients including medical practices, health systems, health plans, and government military organizations. NeuroFlow's business model revolves around integrating behavioral health into patient care, offering personalized, evidence-based tools and resources to improve mental health outcomes. The platform enables healthcare professionals to deliver collaborative, measurement-based care at scale, manage costs of care through remote member engagement, and adjust treatment plans with integrated, coordinated care. NeuroFlow generates revenue through subscription fees for its platform, which is used by thousands of healthcare professionals to enhance patient wellness, readiness, and resiliency. The company also offers a secure mobile app for individuals to support and strengthen their mind-body connection.
Keywords: mental health, remote tracking, behavioral health integration, personalized tools, evidence-based, healthcare technology, patient care, cost management, wellness, resiliency.